2017
DOI: 10.3390/vetsci4010019
|View full text |Cite
|
Sign up to set email alerts
|

Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review

Abstract: In the global human population, the leading cause of non-communicable death is cardiovascular disease. It is predicted that by 2030, deaths attributable to cardiovascular disease will have risen to over 20 million per year. This review compares the cardiomyopathies in both human and non-human animals and identifies the genetic associations for each disorder in each species/taxonomic group. Despite differences between species, advances in human medicine can be gained by utilising animal models of cardiac diseas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0
2

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(29 citation statements)
references
References 225 publications
0
27
0
2
Order By: Relevance
“…To date no large scale study has investigated whether the disease causing mutations seen in humans and other mammals are also present in birds. In total the myosins, cardiac myosin binding protein C and troponin gene account for over 90% of the known causative mutations in human hypertrophic cardiomyopathy [94], for example. Tropomyosin I, which is associated with both actin and troponin T has also been shown to present with cardiomyopathy associated mutations in humans and more recently abnormal atrial septation, ventricular trabeculae and looping in genetic knockdown developing chickens [95].…”
Section: Cardiomyopathiesmentioning
confidence: 99%
“…To date no large scale study has investigated whether the disease causing mutations seen in humans and other mammals are also present in birds. In total the myosins, cardiac myosin binding protein C and troponin gene account for over 90% of the known causative mutations in human hypertrophic cardiomyopathy [94], for example. Tropomyosin I, which is associated with both actin and troponin T has also been shown to present with cardiomyopathy associated mutations in humans and more recently abnormal atrial septation, ventricular trabeculae and looping in genetic knockdown developing chickens [95].…”
Section: Cardiomyopathiesmentioning
confidence: 99%
“…(2) which mutations in those genes could be associated with getting cardiomyopathy; and (3) does having two or more of these mutations affect whether a dog might get cardiomyopathy? Some dogs have very high levels of cardiomyopathy-up to 50% in some breeds [3,4]. We already know that mutations in over 50 different places on the chromosomes can cause human dilated cardiomyopathy, but there are more mutations to find in people and very few studies have looked at mutations in dogs.…”
Section: Searching For Mutations In Dogs With Cardiomyopathymentioning
confidence: 99%
“…Dilated cardiomyopathy is a common disease in large breed dogs [1,2] that are characterized by progressive left-sided or bilateral heart chamber dilatation and a decrease in systolic function [3,4]. As a general rule, dilated cardiomyopathy in dogs progresses rapidly, and the prognosis for the condition is unfavorable [5-7]. However, there is considerable breed variability in the rate of progression of congestive heart failure (CHF) in affected dogs [1,7].…”
Section: Introductionmentioning
confidence: 99%
“…In addition to the toxic effects of the products of aseptic inflammation, stasis and hypoxia of the stomach and intestines lead to the development of malabsorption syndrome, impaired tissue metabolism, and reduced liver detoxification. All of these then lead to the development of endogenous intoxication and secondary damage to the other internal organs, which is irreversible [7,15-17].…”
Section: Introductionmentioning
confidence: 99%